Intellectual Property News - Secerna LLP

Cell Therapy

In-depth Series: EPO Case Law relating to cell therapies: a summary of 2025

European Industry News News 29/01/2026

Here, we take a closer look at a selection of decisions from 2025 that highlight the recent patentability and procedural issues seen in the field of cell-based therapeutics.

Read more

Halloween IP

Industry news, News 29/10/2024

Halloween Patents: How IP Law Governs the Spookiest Holiday of the Year

T251018 – Exceptions To Patentability And Novelty Of Naturally Occurring Substances

Industry news, News 23/10/2024

T2510/18 – Exceptions to Patentability and Novelty of Naturally Occurring Substances

Copyright European Union. (1)

European, Industry news, News 22/10/2024

EU Council Approves Modernised Design Protection Package

AgriTech and Intellectual Property

Industry news, News 17/10/2024

AgriTech and Intellectual Property

Secerna Interior Shots September 2024 002

Industry news, News, Team news 08/10/2024

Secerna LLP Strengthens Chemistry & Pharmaceutical Team with New Patent Attorney

Mpox: Emerging Challenges and Pharmaceutical Innovations in the Face of a Global Health Crisis (Main)

Industry news, News 07/10/2024

Mpox: Emerging Challenges and Pharmaceutical Innovations in the Face of a Global Health Crisis

Navigating Employee Inventor Rights

Industry news, News 30/09/2024

Navigating Employee Inventor Rights

Secerna Highlights IP Importance on "Why Small Business Matters" Podcast

Events, Industry news, News 25/09/2024

Secerna Highlights IP Importance on "Why Small Business Matters" Podcast

Morning Sickness Drugs Repurposing

News 17/09/2024

Morning Sickness: The Role of Drug Repurposing and Intellectual Property Considerations

12 13 14 15 16 17 18 19 20 21 22